Coeptis Therapeutics Holdings, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-24.4% -$464K
$-2M
Free Cash Flow↓-24.4% -$464K
$-2M
Investing Cash Flow↓-100.0% -$100K
$0
Financing Cash Flow↑+235.2% +$2M
$2M
Capex
—
Stock-Based Comp
$300K
D&A↑+18.0% +$45K
$295K
SBC Allocated Expense
$300K